Inventia Healthcare Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- F1-F1/1-F75/1, Additional Ambernath MIDC Ambernath (East), Thane, Maharashtra 421506, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3008232264 · DUNS 677604412
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-02-12
- VAIDrug Quality Assurance2019-07-05
- NAIDrug Quality Assurance2015-08-21
- NAIDrug Quality Assurance2013-05-10
Drugs this plant is listed as making
11 distinct drugs across 35 products name this site in their FDA label.
- Buspirone HydrochlorideApnar Pharma Lp
- ChlorthalidoneRising Pharma Holdings, Inc.
- duloxetineInventia Healthcare Limited.
- fluoxetine hydrochlorideNivagen Pharmaceuticals, Inc.
- iloperidoneMylan Pharmaceuticals Inc.
- LansoprazoleLifestar Pharma LLC.
- Nitrofurantoin (monohydrate/macrocrystals)Jubilant Cadista Pharmaceuticals Inc.
- olmesartan medoxomilInventia Healthcare Limited
- telmisartanAscend Laboratories, LLC
- Venlafaxine HydrochlorideAdvagen Pharma Ltd.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.